These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18479914)

  • 21. Benzo[c][2,7]naphthyridines as inhibitors of PDK-1.
    Kim KH; Wissner A; Floyd MB; Fraser HL; Wang YD; Dushin RG; Hu Y; Olland A; Guo B; Arndt K
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5225-8. PubMed ID: 19628388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling.
    Chao WR; Yean D; Amin K; Green C; Jong L
    J Med Chem; 2007 Jul; 50(15):3412-5. PubMed ID: 17602463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells.
    Barve V; Ahmed F; Adsule S; Banerjee S; Kulkarni S; Katiyar P; Anson CE; Powell AK; Padhye S; Sarkar FH
    J Med Chem; 2006 Jun; 49(13):3800-8. PubMed ID: 16789737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.
    Mastalarz H; Jasztold-Howorko R; Rulko F; Croisy A; Carrez D
    Arch Pharm (Weinheim); 2004 Aug; 337(8):434-9. PubMed ID: 15293262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines.
    Rudys S; Ríos-Luci C; Pérez-Roth E; Cikotiene I; Padrón JM
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1504-6. PubMed ID: 20144871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Zhu S; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5585-9. PubMed ID: 15482929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
    Tsuzuki Y; Tomita K; Sato Y; Kashimoto S; Chiba K
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3189-93. PubMed ID: 15149673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid assembly of diverse and potent allosteric Akt inhibitors.
    Wu Z; Robinson RG; Fu S; Barnett SF; Defeo-Jones D; Jones RE; Kral AM; Huber HE; Kohl NE; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2211-4. PubMed ID: 18296048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h] [1,6]naphthyridin-6-one (ARC-111) and its 12-aza analog via quaternary ammonium intermediates.
    Feng W; Satyanarayana M; Tsai YC; Liu AA; Liu LF; Lavoie EJ
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3570-2. PubMed ID: 18511275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of pyridopyrimidines as potent Akt1/2 inhibitors.
    Wu Z; Hartnett JC; Neilson LA; Robinson RG; Fu S; Barnett SF; Defeo-Jones D; Jones RE; Kral AM; Huber HE; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1274-9. PubMed ID: 18249537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of potent and cell-active allosteric dual Akt 1 and 2 inhibitors.
    Siu T; Liang J; Arruda J; Li Y; Jones RE; Defeo-Jones D; Barnett SF; Robinson RG
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4186-90. PubMed ID: 18539456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel substituted naphthyridines as potential c-Met kinase inhibitors based on MK-2461.
    Wu JF; Liu MM; Huang SX; Wang Y
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3251-5. PubMed ID: 26077488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity.
    Singh SK; Ruchelman AL; Li TK; Liu A; Liu LF; LaVoie EJ
    J Med Chem; 2003 May; 46(11):2254-7. PubMed ID: 12747798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationship studies of cytotoxic anhydrovinblastine amide derivatives.
    Shao Y; Zhang HK; Ding H; Quan HT; Lou LG; Hu LH
    J Nat Prod; 2009 Jun; 72(6):1170-7. PubMed ID: 19499938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases.
    Claridge S; Raeppel F; Granger MC; Bernstein N; Saavedra O; Zhan L; Llewellyn D; Wahhab A; Deziel R; Rahil J; Beaulieu N; Nguyen H; Dupont I; Barsalou A; Beaulieu C; Chute I; Gravel S; Robert MF; Lefebvre S; Dubay M; Pascal R; Gillespie J; Jin Z; Wang J; Besterman JM; MacLeod AR; Vaisburg A
    Bioorg Med Chem Lett; 2008 May; 18(9):2793-8. PubMed ID: 18434145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.
    Bruncko M; Oost TK; Belli BA; Ding H; Joseph MK; Kunzer A; Martineau D; McClellan WJ; Mitten M; Ng SC; Nimmer PM; Oltersdorf T; Park CM; Petros AM; Shoemaker AR; Song X; Wang X; Wendt MD; Zhang H; Fesik SW; Rosenberg SH; Elmore SW
    J Med Chem; 2007 Feb; 50(4):641-62. PubMed ID: 17256834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of selective, ATP-competitive inhibitors of Akt.
    Freeman-Cook KD; Autry C; Borzillo G; Gordon D; Barbacci-Tobin E; Bernardo V; Briere D; Clark T; Corbett M; Jakubczak J; Kakar S; Knauth E; Lippa B; Luzzio MJ; Mansour M; Martinelli G; Marx M; Nelson K; Pandit J; Rajamohan F; Robinson S; Subramanyam C; Wei L; Wythes M; Morris J
    J Med Chem; 2010 Jun; 53(12):4615-22. PubMed ID: 20481595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives.
    Srivastava SK; Jaggi M; Singh AT; Madan A; Rani N; Vishnoi M; Agarwal SK; Mukherjee R; Burman AC
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6660-4. PubMed ID: 17950602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
    Wang H; Yu N; Song H; Chen D; Zou Y; Deng W; Lye PL; Chang J; Ng M; Sun ET; Sangthongpitag K; Wang X; Wu X; Khng HH; Fang L; Goh SK; Ong WC; Bonday Z; Stünkel W; Poulsen A; Entzeroth M
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1403-8. PubMed ID: 19181524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.